Upstream Bio Statistics
NASDAQ: UPBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.59-0.41 (-20.50%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Upstream Bio by the numbers
Upstream Bio has a market capitalization of $87.2 million based on 54.81M shares outstanding. With trailing EPS of $-3.01, Upstream Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 58.6% below its 50-day average and 77.9% below its 200-day average.
Average daily trading volume is 1.01M shares, or about $1.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
UPB valuation vs. peer median
| Metric | UPB | Peer median | Difference |
|---|---|---|---|
| Market cap | $87.15M | $87.41M | -0% |
| Avg. volume | 1.01M | 306.02K | +229% |
Peer median across 8 companies: EQ, RTSN, CPIX, ANIX, NTHI, CATX, OGI, HURA.
Valuation
- Market cap
- $87.15M
- Price / sales (latest FY)
- 30.54
- EPS (TTM)
- $-3.01
- Shares outstanding
- 54.81M
Price and trading
- Previous close
- 2.00
- Open
- 1.98
- Day range
- 1.56 – 2.06
- 52-week range
- 1.56 – 33.68
- 52-week change
- -93.78%
- Beta
- —
- Volume
- 1.39M
- Average volume
- 1.01M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 87.15M
- Forward Pe
- -0.60
- Eps
- -3.01
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 33.68
- Week52 Low
- 1.56
- Avg Volume
- 1.01M
- Shares Outstanding
- 54.81M
- Ma50
- 3.84
- Ma200
- 7.20
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -95.28%
- Pct From52w Low
- 1.92%